亚日韩在线中文字幕亚洲,国产在线播放鲁啊鲁视频,张柏芝手扒性器全部图片,亚洲成无码电影在线观看

Amycolatopsis rifamycinica 拉丁名

(ATCC? 21789?) 統(tǒng)一編號

Deposited As Streptomyces mediterranei Margalith and Beretta

Strain Designations 菌株別名 M 18

Application 用途 Produces rifamycin B nancimycin

Biosafety Level 生物安全等級 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format 提供形式freeze-dried

Preceptrol? no

Type Strain 模式菌株 no

Medium 培養(yǎng)基 ATCC? Medium 1877: ISP Medium 1

ATCC? Medium 196: Yeast malt extract agar

Growth Conditions 生長條件

Temperature 培養(yǎng)溫度: 26.0℃

Name of Depositor 寄存人 Gruppo Lepetit S.p.A. U.S. Patent Number 3,843,449

Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.

References 參考文獻(xiàn) White RJ, Lancini G. Production of rifamycin B.

US Patent 3,871,965 dated Mar 18 1975 Lechevalier MP, et al. Two new genera of nocardioform Actinomycetes: Amycolata gen. nov. and Amycolatopsis gen. nov.. Int. J. Syst. Bacteriol. 36: 29-37, 1986. Bala S, et al. Reclassification of Amycolatopsis mediterranei DSM 46095 as Amycolatopsis rifamycinica sp. nov.. Int. J. Syst. Evol. Microbiol. 54: 1145-1149, 2004. PubMed: 15280283